Among these nine GM-related genes, ATP13A4, PIK3C2A, CD164, PHF1, CES2, and PDGFB were found to be overexpressed in the high-risk group and are promising targets for AD prediction and treatment. Here, ATP13A4 is linked to Alzheimer disease.